Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| TALPHERA, INC.TLPH · Entity 7102 | Chief Medical Officer | May 20, 2026 | May 21, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
TALPHERA, INC.
Report date May 20, 2026 · Filed May 21, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 76,542 |
Reported balance
After 2026-05-20 transaction · row 1
1 source rowRow 1 · 2026-05-20 · Tax withholding · Disposed 4,518 · Balance 76,542 F1: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 20, 2026 Filed May 21, 2026 21:01 UTC | TALPHERA, INC. TLPH · Entity 7102 | Tax withholdingCommon Stock | 4,518 | $0.82 | $3,722.83 |
DisclosureSEC source: 0002040805-26-000005 · form4-05212026_090524.xml · nonDerivative · entry 1 Aslam Shakil · CIK 0002040805 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,542 F1 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs. Read SEC document |
| April 02, 2026 Filed Apr 3, 2026 22:08 UTC | TALPHERA, INC. TLPH · Entity 7102 | Tax withholdingCommon Stock | 2,118 | $0.72 | $1,529.83 |
DisclosureSEC source: 0002040805-26-000003 · form4-04032026_100457.xml · nonDerivative · entry 1 Aslam Shakil · CIK 0002040805 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,060 F1 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs. Read SEC document |
| February 12, 2026 Filed Feb 21, 2026 01:27 UTC | TALPHERA, INC. TLPH · Entity 7102 | GrantStock Option (Right to Buy) · Derivative | 205,000 | $0.00 Strike: $0.81 | $0.00 |
DisclosureSEC source: 0002040805-26-000002 · form4-02212026_010259.xml · derivative · entry 2 Aslam Shakil · CIK 0002040805 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 205,000 Underlying: Common Stock · 205,000 shares Expires 2036-02-11 F2 · derivative.exercise_date: On February 12, 2026, the reporting person was granted an option to purchase 205,000 shares of common stock. One fourth (1/4th) of the option shares shall vest on the one year anniversary of the grant date, and the remaining balance of the option shares shall vest in 36 equal consecutive monthly installments thereafter until fully vested so long as the reporting person remains in continuous service through such applicable vesting periods. Read SEC document |
| February 12, 2026 Filed Feb 21, 2026 01:27 UTC | TALPHERA, INC. TLPH · Entity 7102 | PurchaseCommon Stock | 35,000 | $0.81 | $28,430.50 |
DisclosureSEC source: 0002040805-26-000002 · form4-02212026_010259.xml · nonDerivative · entry 1 Aslam Shakil · CIK 0002040805 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,178 F1 · shares: The restricted stock units shall vest in three equal consecutive annual installments on February 12, 2027, February 12, 2028 and February 12, 2029. Read SEC document |
| May 20, 2025 Filed May 21, 2025 22:57 UTC | TALPHERA, INC. TLPH · Entity 7102 | Tax withholdingCommom Stock | 4,517 | $0.52 | $2,328.51 |
DisclosureSEC source: 0001415889-25-013995 · form4-05212025_100513.xml · nonDerivative · entry 1 Aslam Shakil · CIK 0002040805 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,178 F1 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs. Read SEC document |
| April 02, 2025 Filed Apr 3, 2025 20:31 UTC | TALPHERA, INC. TLPH · Entity 7102 | GrantStock Option (Right to Buy) · Derivative | 80,000 | $0.00 Strike: $0.58 | $0.00 |
DisclosureSEC source: 0001415889-25-009965 · form4-04032025_080416.xml · derivative · entry 2 Aslam Shakil · CIK 0002040805 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2035-04-01 F2 · derivative.exercise_date: On April 2, 2025, the reporting person was granted an option to purchase 80,000 shares of common stock. One fourth (1/4th) of the option shares shall vest on the one year anniversary of the grant date, and the remaining balance of the option shares shall vest in 36 equal consecutive monthly installments thereafter until fully vested so long as the reporting person remains in continuous service through such applicable vesting periods. Read SEC document |
| April 02, 2025 Filed Apr 3, 2025 20:31 UTC | TALPHERA, INC. TLPH · Entity 7102 | GrantCommom Stock | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-009965 · form4-04032025_080416.xml · nonDerivative · entry 1 Aslam Shakil · CIK 0002040805 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,695 F1 · shares: The restricted stock units shall vest in three equal consecutive annual installments on April 2, 2026, April 2, 2027 and April 2, 2028. Read SEC document |
| June 14, 2024 Filed Feb 26, 2025 23:52 UTC | TALPHERA, INC. TLPH · Entity 7102 | PurchaseCommon Stock | 5,000 | $1.07 | $5,357.00 |
DisclosureSEC source: 0001415889-25-005730 · form4-02262025_110201.xml · nonDerivative · entry 2 Aslam Shakil · CIK 0002040805 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,695 F1 · shares: Price reported is a weighted-average sales price. The shares were purchased at prices ranging from $1.07 to $1.08. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 13, 2024 Filed Feb 26, 2025 23:52 UTC | TALPHERA, INC. TLPH · Entity 7102 | PurchaseCommon Stock | 695 | $0.98 | $681.10 |
DisclosureSEC source: 0001415889-25-005730 · form4-02262025_110201.xml · nonDerivative · entry 1 Aslam Shakil · CIK 0002040805 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,695 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.